Figure 1
Figure 1. GAL1 expression in BM cells. Different BM subpopulations were analyzed for intracellular expression of GAL1 by flow cytometry. GAL1 intracellular staining in C57Bl/6 mice (unshaded) was compared with GAL1−/− mice as a negative control (shaded). The gating strategy is shown in the figure, and the cellular subsets were defined as follows: (A) Pro-B/pre-B (CD19+B220+IgM−IgD−), immature B (CD19+B220+IgM+IgD−), and recirculating B cells (CD19+B220+IgM+IgD+). (B) CD117+ hematopoietic progenitors (Ter119−CD19−B220−CD3−Gr1−CD117+). (C) Immature myeloid cells (CD11b+Gr1+), granulocytes (CD11bhiGr1hi). (D) NK (NK1.1+CD3−), NKT (NK1.1+CD3+), and T cells (NK1.1−CD3+). (E) Erythrocytes (Ter119+). (F) Plasmacytoid dendritic cells (CD11c+B220+). (G) Lymphoid DC (CD11c+CD11b−) and myeloid DC (CD11c+CD11b+). (H) BM stromal cells (CD45−Lin−). The lineage (Lin) staining corresponds to a mix of Ter119, CD19, CD11c, CD117, and Gr1.

GAL1 expression in BM cells. Different BM subpopulations were analyzed for intracellular expression of GAL1 by flow cytometry. GAL1 intracellular staining in C57Bl/6 mice (unshaded) was compared with GAL1−/− mice as a negative control (shaded). The gating strategy is shown in the figure, and the cellular subsets were defined as follows: (A) Pro-B/pre-B (CD19+B220+IgMIgD), immature B (CD19+B220+IgM+IgD), and recirculating B cells (CD19+B220+IgM+IgD+). (B) CD117+ hematopoietic progenitors (Ter119CD19B220CD3Gr1CD117+). (C) Immature myeloid cells (CD11b+Gr1+), granulocytes (CD11bhiGr1hi). (D) NK (NK1.1+CD3), NKT (NK1.1+CD3+), and T cells (NK1.1CD3+). (E) Erythrocytes (Ter119+). (F) Plasmacytoid dendritic cells (CD11c+B220+). (G) Lymphoid DC (CD11c+CD11b) and myeloid DC (CD11c+CD11b+). (H) BM stromal cells (CD45Lin). The lineage (Lin) staining corresponds to a mix of Ter119, CD19, CD11c, CD117, and Gr1.

Close Modal

or Create an Account

Close Modal
Close Modal